AI Ambient Scribe in Psychiatry (AASP)
18 de agosto de 2026 actualizado por: Maja Dobelsek, MD, Psychiatrie St. Gallen
Evaluating the Use of an Artificial Intelligence Ambient Scribe in a Swiss Psychiatric Clinic: Efficiency, Documentation Quality, and Therapeutic Alliance
The goal of this clinical trial is to learn if an artificial intelligence (AI) tool that listens to appointments and drafts clinical notes can help clinicians in psychiatric care. Researchers also want to know if the tool changes how patients experience their care. The study includes mental health care providers (physicians, psychologists/psychotherapists, nurses, and social workers) at Psychiatrie St. Gallen and the adult patients they see in their appointments.
The main questions it aims to answer are:
- Does the AI tool lower the time clinicians spend writing notes?
- Are notes written with the AI tool as good as or better than notes written without it?
- Do patients notice a difference in their relationship with their clinician when the tool is used?
Researchers will compare clinicians who use the AI tool to clinicians who keep writing notes their usual way, before and during the intervention period, to see if writing time, note quality, and the patient-rated therapeutic relationship differ between the two groups.
Clinicians will:
Join one of two groups. One group starts using the AI tool on August 14, 2026. The other group keeps writing notes the usual way. Both groups will be observed until the end of November 2026, with note quality evaluation completed in December 2026. Clinicians who cannot contribute to all measurements may, with their consent, remain in the study for automated measurement of documentation time only.
Patients will:
- Be invited to fill out a short, anonymous survey about their experience with their clinician.
- Be asked to agree, in writing, that researchers may review the report from their initial assessment appointment.
Descripción general del estudio
Estado
Activo, no reclutando
Condiciones
Intervención / Tratamiento
Tipo de estudio
Intervencionista
Inscripción (Actual)
47
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
Canton of St. Gallen
-
Heerbrugg, Canton of St. Gallen, Suiza, 9435
- Psychiatrie St. Gallen
-
Pfäfers Dorf, Canton of St. Gallen, Suiza, 7312
- Psychiatrie St. Gallen
-
Rorschach, Canton of St. Gallen, Suiza, 9400
- Psychiatrie St. Gallen
-
Sankt Gallen, Canton of St. Gallen, Suiza, 9000
- Psychiatrie St. Gallen
-
Sargans, Canton of St. Gallen, Suiza, 7320
- Psychiatrie St. Gallen
-
Uznach, Canton of St. Gallen, Suiza, 8730
- Psychiatrie St. Gallen
-
Wattwil, Canton of St. Gallen, Suiza, 9630
- Psychiatrie St. Gallen
-
Wil, Canton of St. Gallen, Suiza, 9500
- Psychiatrie St. Gallen
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Sí
Descripción
The observed study population comprises mental health care providers (physicians, psychologists/psychotherapists, nurses, and social workers) employed at Psychiatrie St. Gallen.
Provider Inclusion Criteria:
- Readiness to use an artificial intelligence ambient scribe during patient consultations (intervention group)
- Regular clinical consultations with adult psychiatric patients
Two outcome-specific criteria apply: contribution to the report quality outcomes requires that the provider regularly conducts new-patient intakes and writes initial psychiatric assessment reports; contribution to the patient-reported outcomes requires working in the outpatient setting. Providers who cannot or no longer wish to contribute to any actively collected outcome may, with their consent, remain enrolled for passive documentation-time measurement only; for analysis, such providers stay in the group which was fixed at enrollment..
Provider Exclusion Criteria:
- notice of termination of the employment contract given during the data collection period
- Working in the dementia inpatient clinic
Patients are not the observed population, but anonymous ratings of their subjective consultation experience are collected from them, and written consent for the review of initial assessment reports is obtained.
Patient Inclusion Criteria:
- All adult patients visiting the outpatient clinic during the data collection periods for a consultation with a participating provider
Patient Exclusion Criteria:
- Insufficient German proficiency (below level B2)
- Cognitive impairment precluding informed participation
- Acute psychosis, acute suicidality, mania, or intoxication
- Severe emotional distress
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Investigación de servicios de salud
- Asignación: No aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: Control Group
The mental health care providers (physicians, psychologists/psychotherapists, nurses, and social workers) in this group document their consultations as usual (typing or conventional dictation), without access to the ambient scribe.
Under institutional policy, all clinicians irrespective of study participation may use general-purpose AI tools for administrative and documentation support, provided no patient-identifying data are entered; the control condition is therefore defined as documentation without the ambient scribe, not as documentation without any AI assistance.
|
|
|
Experimental: AI-Group
The mental health care providers in this group use an AI ambient scribe to create their clinical notes from consultations, beginning August 14, 2026.
|
Listener Tool of the SwissGPT application (AlpineAI AG).
After the patient's verbal consent, the provider records the consultation audio via mobile phone or laptop.
All audio and text data are processed exclusively on AlpineAI's own GPU infrastructure located in Switzerland and are encrypted with individual keys per customer and per data type.
Transcription uses the speech-to-text models Whisper 3 Turbo; from the transcript, a draft clinical note is generated by open-weight large language model Mistral Large 3 based on a standardized prompt developed for the institution.
The provider transfers the generated draft note unedited into the electronic health record (ORBIS) and performs all review and editing directly in the EHR, so that the effort of correcting AI-generated drafts is captured by the automated documentation-time measurement.
Audio recordings and transcripts are automatically deleted after 30 days.
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Time spent on psychiatric documentation
Periodo de tiempo: 24 Weeks
|
Mean minutes spent writing clinical notes (progress notes, initial psychiatric assessment reports, and discharge letters), extracted automatically from EHR (ORBIS) audit logs as form-level editing durations, compared pre-intervention vs. during intervention between groups.
|
24 Weeks
|
|
Documentation quality of initial psychiatric asessment reports
Periodo de tiempo: 24 Weeks
|
Quality of initial psychiatric assessment reports rated with the Physician Documentation Quality Instrument, 9-item version (PDQI-9).
Each of the 9 items is scored on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree) and summed to a total score ranging from 9 (minimum) to 45 (maximum); higher scores indicate better documentation quality.
Each report is independently rated by 2 of 8 experienced mental health specialists in a balanced rotating-pair design, blinded to provider identity, group, time point, and site.
|
24 Weeks
|
|
Working Alliance
Periodo de tiempo: 5 weeks pre intervention and 5 weeks during the intervention.
|
Patient-rated working alliance measured with the Working Alliance Inventory-Short Revised, German patient version (WAI-SR).
The 12 items are each scored on a 5-point scale (1 to 5) and summed to a total score ranging from 12 (minimum) to 60 (maximum); higher scores indicate a stronger (better) working alliance.
Reported anonymously by patients after outpatient consultations.
In addition to the two-sided superiority test, non-inferiority is prespecified: a lower bound of the two-sided 95% CI of the difference-in-differences estimate above -3.5 WAI-SR sum-scale points will be interpreted as evidence against a clinically relevant deterioration of the alliance.
|
5 weeks pre intervention and 5 weeks during the intervention.
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Time passed from initial psychiatric assessment note creation to its completion
Periodo de tiempo: 24 Weeks
|
Calendar time from the administrative creation of the initial psychiatric assessment note in the EHR to its completion, capturing documentation backlog.
This outcome is separate from total active time spent writing the note.
|
24 Weeks
|
|
Guideline-relevant information coverage and density in initial psychiatric assessment reports
Periodo de tiempo: 24 Weeks
|
Coverage and density of guideline-relevant psychiatric assessment content, scored by a large language model (SwissGPT) against a 71-item checklist derived from the American Psychiatric Association practice guidelines for the psychiatric evaluation of adults.
Each item is scored as covered (1), partially covered (0.5), or not covered (0); report length in characters is used to compute information density.
|
24 Weeks
|
|
Patient-perceived empathy of mental health care providers during consultations
Periodo de tiempo: 5 weeks pre intervention and 5 weeks during the intervention.
|
Patient-perceived empathy measured with the Consultation and Relational Empathy (CARE) measure.
The 10 items are each scored on a 5-point scale (1 = poor to 5 = excellent) and summed to a total score ranging from 10 (minimum) to 50 (maximum); higher scores indicate greater perceived empathy (better).
Completed anonymously by patients alongside the WAI-SR.
A study-specific German translation is used; its psychometric properties will be examined and reported.
|
5 weeks pre intervention and 5 weeks during the intervention.
|
|
Documentation quality of ambient scribe-generated initial psychiatric assessment reports (raw AI output)
Periodo de tiempo: 15 Weeks
|
AI-generated initial psychiatric assessment reports, exactly as produced by the ambient scribe and before any human correction, rated by the generating providers (intervention group only) with the Provider Documentation Summarization Quality Instrument (PDSQI-9), an LLM-adapted 9-attribute instrument screening for hallucinations, omissions, redundancy, and biased language.
Each attribute is scored on a 5-point scale (1 to 5) and summed to a total score ranging from 9 (minimum) to 45 (maximum); higher scores indicate better quality of the AI-generated summary.
|
15 Weeks
|
|
Clinician Burnout
Periodo de tiempo: 5 weeks in the pre-intervention period and the last Week (Week 15) of the post-intervention period.
|
Work-related burnout of participating providers in both groups, measured with the German version of the Burnout Assessment Tool (BAT).
The 23 core-symptom items (subscales: exhaustion, mental distance, cognitive impairment, emotional impairment) are each scored on a 5-point frequency scale (1 = never to 5 = always) and averaged to a core score ranging from 1.00 (minimum) to 5.00 (maximum); higher scores indicate more burnout symptoms (worse outcome).
The 10 secondary-symptom items are scored and averaged on the same 1.00-5.00
metric, with higher scores likewise indicating a worse outcome.
|
5 weeks in the pre-intervention period and the last Week (Week 15) of the post-intervention period.
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Maja Dobelsek, MD, Universität St. Gallen
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
13 de julio de 2026
Finalización primaria (Estimado)
31 de diciembre de 2026
Finalización del estudio (Estimado)
31 de diciembre de 2026
Fechas de registro del estudio
Enviado por primera vez
6 de agosto de 2026
Primero enviado que cumplió con los criterios de control de calidad
18 de agosto de 2026
Publicado por primera vez (Actual)
20 de agosto de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
20 de agosto de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
18 de agosto de 2026
Última verificación
1 de agosto de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- S012026
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .